ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

North Dakota reports 3 COVID-19 deaths

Active virus cases fell from nearly 3,400 to 2,883 on Monday after low-weekend testing.

coronavirus.jpg
A coronavirus graphic. Courtesy of the Centers for Disease Control and Prevention
We are part of The Trust Project.

BISMARCK —The following are COVID-19 case rates, deaths and hospitalizations tracked by the state Department of Health as of Monday, Dec. 6. Because all data are preliminary, some numbers and totals may change from one day to the next.

Statewide case rates

  • NEW CASES REPORTED FRIDAY, DEC. 3: 741
  • ACTIVE CASES: 2,883
  • DAILY POSITIVITY RATE: 16%
  • TOTAL KNOWN CASES THROUGHOUT PANDEMIC: 164,811
  • TOTAL RECOVERED THROUGHOUT PANDEMIC: 160,013

The state's 14-day rolling average positivity rate is 7.6%.

Hospitalizations, deaths

  • ACTIVE HOSPITALIZATIONS: 172

  • DEATHS SINCE FRIDAY, DEC. 3: 3

  • TOTAL DEATHS: 1,915

The health department has reported four COVID-19 deaths so far in the month of December. The department recorded 167 virus-related deaths in October and 118 in November, by far the deadliest months of the pandemic in North Dakota this year.

Vaccinations

  • FIRST DOSE ADMINISTERED: 446,013 (57.2% of population)

  • FULL VACCINE COVERAGE: 370,971 (48.1% of population)

  • BOOSTER DOSES ADMINISTERED: 125,991 (16.2% of population)

The top two figures come from the Centers for Disease Control and Prevention , which includes vaccinations performed at federal sites, while the bottom figure comes from the state's vaccine dashboard , which gives a fuller picture of booster and third doses.

The Department of Health encourages individuals to get information about vaccines at www.health.nd.gov/covidvaccinelocator .

ADVERTISEMENT

As a public service, we’ve opened this article to everyone regardless of subscription status. If this coverage is important to you, please consider supporting local journalism by clicking on the subscribe button in the upper righthand corner of the homepage.

Readers can reach reporter Adam Willis, a Report for America corps member, at awillis@forumcomm.com.

What to read next
Bebtelovimab is designed as a treatment option for those newly diagnosed with COVID-19 who cannot take Paxlovid and are deemed at high risk of severe outcomes. It replaces a series of monoclonal treatments that no longer are effective against virus due to mutation.
The JRMC Cancer Center, which was fully funded by donors in the community, started seeing patients in June 2019.
For decades, the drug industry has yelled bloody murder each time Congress considered a regulatory measure that threatened its profits. But the hyperbole reached a new pitch in recent weeks as the Senate moved to adopt modest drug pricing negotiation measures in the Inflation Reduction Act.
Sanford Health’s Program for Addiction Recovery provided Tanner Lene a way to connect to a heritage he’d left largely unexplored, as he began to learn Ojibwe and join classes taught by elders and knowledge keepers on traditional medicines and art.